cDC1 cells could improve cancer immunotherapy – Drug Target Review
|
cDC1 cells could improve cancer immunotherapy
Drug Target Review Scientists have discovered that immune cells called Natural Killer cells accumulate in tumours and release chemicals that attract specialised dendritic cells (cDC1) – white blood cells known for triggering anti-cancer immune responses – to the tumour … |
